Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
1.730
-0.010 (-0.57%)
Oct 26, 2026, 1:23 PM EDT - Market open
Voyager Therapeutics Employees
Voyager Therapeutics had 141 employees as of December 31, 2025. The number of employees decreased by 31 or 18.02% compared to the previous year. That makes Voyager Therapeutics the 29,295th largest employer in the world and 3,728th in the United States.
Employees
141
Change (1Y)
-31
Growth (1Y)
-18.02%
Revenue / Employee
$244,390
Profits / Employee
-$764,028
Market Cap
106.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 141 | -31 | -18.02% | 141 | 0 |
| Dec 31, 2024 | 172 | 10 | 6.17% | 172 | 0 |
| Dec 31, 2023 | 162 | 37 | 29.60% | 162 | 0 |
| Dec 31, 2022 | 125 | 24 | 23.76% | 125 | 0 |
| Dec 31, 2021 | 101 | -78 | -43.58% | 101 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 124 |
| Cibus | 118 |
| enGene Therapeutics | 82 |
| PolyPid | 75 |
| Unicycive Therapeutics | 22 |
| Black Diamond Therapeutics | 21 |
| Tevogen | 18 |
| Minerva Neurosciences | 7 |
VYGR News
- 5 days ago - Voyager Therapeutic CEO Alfred Sandrock to depart, Robin Swartz to succeed - TheFly
- 5 days ago - Voyager Announces CEO Succession Plan, Appoints Robin Swartz President - GlobeNewsWire
- 6 weeks ago - Voyager Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 7 weeks ago - Voyager to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Voyager Therapeutics reports Q2 EPS (40c), consensus (51c) - TheFly
- 2 months ago - Voyager Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Voyager Therapeutics Earnings release: Q2 2026 - Filings
- 3 months ago - Voyager Therapeutics presents six-month toxicology data for VY1706 - TheFly